Supplemental material
Open access
2,231
Views
20
CrossRef citations to date
0
Altmetric
REPORTS
An affibody-adalimumab hybrid blocks combined IL-6 and TNF-triggered serum amyloid A secretion in vivo
Feifan YuDivision of Protein Technology; KTH Royal Institute of Technology; AlbaNova University Center; Stockholm, Sweden
, Lindvi GudmundsdotterAffibody Medical AB; Gunnar Asplunds Allé 24; Solna, Sweden
, Anastassja AkalDivision of Protein Technology; KTH Royal Institute of Technology; AlbaNova University Center; Stockholm, Sweden
, Elin GunneriussonAffibody Medical AB; Gunnar Asplunds Allé 24; Solna, Sweden
, Fredrik FrejdAffibody Medical AB; Gunnar Asplunds Allé 24; Solna, Sweden;Department of Radiology, Oncology and Radiation Sciences; Uppsala University; Uppsala, SwedenCorrespondence[email protected] [email protected]
& Per-Åke NygrenDivision of Protein Technology; KTH Royal Institute of Technology; AlbaNova University Center; Stockholm, SwedenCorrespondence[email protected] [email protected]
Pages 1598-1607
|
Received 26 Jun 2014, Accepted 14 Aug 2014, Published online: 15 Dec 2014
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.